Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Discover index funds with standout Sharpe ratios over the last ten years and learn how risk-adjusted performance translates into better risk management.
28,172 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
A surge in AI-focused hardware stocks has lifted semiconductors, yet traders warn that the moment when semi trade tur...
Scammers pretending to be regulators are getting more convincing. This guide helps you spot the red flags, verify leg...
Public family drama can hit the wallet as fast as headlines. This piece examines what the phrase 'tony says hopes bro...
Bitcoin opened higher on the news, but early strength faded as investors weighed geopolitical risk. BlackRock’s 60-da...
If you want to know how a high-speed blockchain could beat Bitcoin in a multi-year window, this guide breaks down the...
A notable fund sold a sizable stake in a leading pet-food company, triggering questions about motive, timing, and imp...
When a pop moment turns personal, fans feel the emotion—and the money questions that follow. This piece translates th...
Two major crypto regulations dropping 2026 are on the horizon, touching stablecoins and market infrastructure. This g...
Investors are pouring into autonomous weapons and defense tech, signaling a shift from software plays to hardware-dri...
Investors often worry about a bear market under political changes. This thoughtful look at the likelihood bear market...
A deep dive into applied digital's stunning rally, the backlog fueling demand, and the tough questions investors must...